Spyre Therapeutics Inc (NAS:SYRE)
$ 35.92 0.79 (2.25%) Market Cap: 1.83 Bil Enterprise Value: 1.63 Bil PE Ratio: 0 PB Ratio: 8.35 GF Score: 51/100

Aeglea Bio Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 08, 2020 / 02:00PM GMT
Release Date Price: $222.25 (-3.89%)
Operator

Good morning and welcome to the 2020 Annual Meeting of Stockholders of Aeglea BioTherapeutics. This meeting is being held in a virtual format due to the COVID-19 pandemic. Due to the nature of the virtual format, we may experience technical difficulties, and we will address any that come up as best as we can.

Our host for today's call is Aeglea's President and Chief Executive Officer, Anthony Quinn. (Operator Instructions)

I would now turn the call over to your host, Dr. Quinn. You may begin.

Anthony G. Quinn
Aeglea BioTherapeutics, Inc. - President, CEO & Director

Thank you, operator. Good morning, everyone. It's a pleasure to welcome you to our Annual Meeting of Stockholders. The meeting is now called to order.

I'd like to introduce the following members of the Board of Directors who are with us on the phone this morning: Russell Cox; Armen Shanafelt; Suzanne Bruhn; Sandy Mahatme; Ivana Liebisch; and Bryan Lawlis. I would also like to introduce our Chief Financial Officer, Charles York, who is with us this morning. Natalie

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot